The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe ... The agency said Friday ...

The Company is commercializing neffy® 2 mg (trade name EURneffy® in the EU) (previously referred to as ARS-1), an epinephrine nasal spray indicated in the U.S. for emergency treatment of Type I ...

Findings in the study demonstrate the benefit of diazepam nasal spray use for both termination of acute seizure clusters and prolonged seizures within clusters. Effect of Diazepam Intervention on ...